BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Rhea-AI Summary
BillionToOne (NASDAQ: BLLN) announced it will report fourth quarter and full year 2025 financial results after market close on March 4, 2026. The company will host a conference call at 1:30 PM PT / 4:30 PM ET the same day and provide a live and archived webcast.
Investors may register to participate in the conference call and access the webcast on BillionToOne's investor relations "Events" page.
Positive
- None.
Negative
- None.
News Market Reaction – BLLN
On the day this news was published, BLLN gained 5.16%, reflecting a notable positive market reaction. Argus tracked a peak move of +5.9% during that session. Argus tracked a trough of -3.9% from its starting point during tracking. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $221M to the company's valuation, bringing the market cap to $4.51B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Previous Earnings date Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 02 | Earnings date notice | Positive | +1.7% | Set Q3 2025 earnings release date and conference call details. |
Prior earnings-date scheduling news saw a modestly positive +1.66% move, suggesting these timing announcements have historically had limited but positive impact.
Over the past several months, BillionToOne reported multiple operational and strategic milestones, including new product launches, a major clinical study selection, and strong 2026 revenue guidance of $415M–$430M with positive GAAP operating income expectations. The current announcement simply schedules the fourth quarter and full-year 2025 results for March 4, 2026, similar to the prior third-quarter 2025 earnings date notice on December 2, 2025. Historically, such earnings-date releases were followed by modest share price gains.
Historical Comparison
In the past, BLLN’s only similar earnings-date notice saw a +1.66% move. Today’s scheduling of Q4 and full-year 2025 results is consistent in nature with that prior event.
Earnings communications progressed from setting the Q3 2025 release date to now scheduling Q4 and full-year 2025 results, maintaining a similar call format and disclosure cadence.
Market Pulse Summary
The stock moved +5.2% in the session following this news. A strong positive reaction aligns with how BLLN previously responded to earnings-date announcements, where the prior event saw a +1.66% move. Traders could have treated the scheduled Q4 and full-year 2025 release on March 4, 2026 as a focal point following earlier guidance calling for $415M–$430M in 2026 revenue. However, such calendar notices alone offer limited new information, so enthusiasm might fade without supportive reported results.
AI-generated analysis. Not financial advice.
MENLO PARK, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that the Company plans to release its financial results for fourth quarter and full year ended December 31, 2025 after the market close on Wednesday, March 4, 2026. BillionToOne will host a conference call to discuss its financial results at 1:30pm Pacific Time / 4:30pm Eastern Time the same day.
To participate in the conference call, please register here before the 1:30pm Pacific Time / 4:30pm Eastern Time start. A live and archived webcast will be available on the “Events” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/.
About BillionToOne
Headquartered in Menlo Park, California, BillionToOne is a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level. For more information, visit www.billiontoone.com.
Investor Contact
ir@billiontoone.com
Media Contact
billiontoone@moxiegrouppr.com
FAQ
When will BillionToOne (BLLN) report Q4 and full year 2025 results?
What time is the BillionToOne (BLLN) earnings conference call on March 4, 2026?
How can investors join the BillionToOne (BLLN) March 4, 2026 webcast and call?
Will BillionToOne (BLLN) provide a replay of the March 4, 2026 earnings webcast?
Where is the BillionToOne (BLLN) investor webcast hosted for the March 4, 2026 results?
